论文信息 - MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions - 字舞流文

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

M. Ladanyi | A. Drilon | M. Kris | S. Toyooka | N. Rosen | D. Solit | Gregory Riely | R. Somwar | M. Sakaguchi | K. Suzawa | E. de Stanchina | M. Davare | M. Mattar | M. Offin | A. Schoenfeld | Daisuke Kubota | Huichun Tai | Besnik Qeriqi | Yue Lu | Hiroki Sato | E. Siau | A. Lui